{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:45:34Z","timestamp":1768340734491,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"crossref","award":["202007030010"],"award-info":[{"award-number":["202007030010"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases","award":["2020B1212060017"],"award-info":[{"award-number":["2020B1212060017"]}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases","award":["2020B1111170002"],"award-info":[{"award-number":["2020B1111170002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Rare neurological diseases (RNDs) result in severe health burdens worldwide. Data from China are limited. We aimed to investigate the health burden of 20 RNDs in Guangdong Province (GD), which contains two-thirds of the population of South China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The hospitalization data of 20 RNDs were described using hospital-based front sheet data from 3,037 hospitals of GD from 2016 to 2022. The 20 RNDs included amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth Disease, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, congenital myotonia, congenital myasthenic syndrome, Dravet syndrome, Fabry disease, hereditary spastic paraplegia, Huntington disease, Leber hereditary optic neuropathy, mitochondrial encephalopathy (ME), multi-focal motor neuropathy, myotonic dystrophy, primary hereditary dystonia, progressive muscular dystrophy (PMD), spinal and bulbar muscular atrophy, spinal muscular atrophy (SMA), spinocerebellar ataxia, Wilson disease (WD) and X-linked adrenoleukodystrophy. Age were presented as mean and standard deviation while length of hospital stay as median and interquartile range (25th and 75th percentiles). The other variables were described as number and percentage. The data were analyzed by Joinpoint regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were 9,351 cases, including 330 ICU and 155 death cases. The average age was 33.7\u2009\u00b1\u200922.0 y, and 63.8% of patients were male. From 2016 to 2022, the number of RND (and juvenile RND) cases were 1034 (184), 1174 (293), 1443 (374), 1422 (320), 1331 (337), 1432 (409) to 1515 (515). ICU (and juvenile ICU) cases rose from 28 (3), 34 (6), 24 (4), 38 (11), 46 (13), 54 (24) to 106 (56). Joinpoint regression showed significant upward trend in percentages of juvenile and juvenile ICU cases (APC\u2009=\u20098.13, <jats:italic>P<\/jats:italic>&lt; 0.05; APC\u2009=\u200928.42, <jats:italic>P<\/jats:italic>&lt; 0.05). The fop five RNDs were WD, ASL, PMD, ME, and SMA, which accounted for 79.7% of all, 99.1% of ICU, and 94.8% of death cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We demonstrated that the increase in health burden of RNDs was mainly evident in juveniles in South China from 2016 to 2022. The top 5 RNDs accounted for majority of the critical patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03704-5","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:24:14Z","timestamp":1744082654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study"],"prefix":"10.1186","volume":"20","author":[{"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-1490","authenticated-orcid":false,"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"6","key":"3704_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, et al. Rare disease terminology and Definitions-A systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906\u201314.","journal-title":"Value Health"},{"issue":"2","key":"3704_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"3704_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13023-019-1165-7","volume":"14","author":"R Min","year":"2019","unstructured":"Min R, Zhang X, Fang P, Wang B, Wang H. Health service security of patients with 8 certain rare diseases: evidence from China\u2019s National system for health service utilization of patients with healthcare insurance. Orphanet J Rare Dis. 2019;14(1):204.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3704_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13023-021-02130-7","volume":"16","author":"J Guo","year":"2021","unstructured":"Guo J, Liu P, Chen L, et al. National rare diseases registry system (NRDRS): China\u2019s first nation-wide rare diseases demographic analyses. Orphanet J Rare Dis. 2021;16(1):515.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3704_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/ene.15267","volume":"29","author":"K Aleksovska","year":"2022","unstructured":"Aleksovska K, Kobulashvili T, Costa J, et al. European academy of neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases. Eur J Neurol. 2022;29(6):1571\u201386.","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"3704_CR6","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S0035-3787(13)70054-7","volume":"169","author":"A Federico","year":"2013","unstructured":"Federico A. Rare neurological diseases: a Pandora\u2019s box for neurology (an European and Italian perspective). Rev Neurol (Paris). 2013;169(Suppl 1):S12\u20137.","journal-title":"Rev Neurol (Paris)"},{"key":"3704_CR7","unstructured":"Administration BoM. National Health Commission of the People\u2019s Republic of China. Notice on issuance of the first list of rare diseases. 2018."},{"issue":"5","key":"3704_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/gim.2016.143","volume":"19","author":"CE Walker","year":"2017","unstructured":"Walker CE, Mahede T, Davis G, et al. The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genet Med. 2017;19(5):546\u201352.","journal-title":"Genet Med"},{"key":"3704_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-9-37","volume":"9","author":"M Mazzucato","year":"2014","unstructured":"Mazzucato M, Visona Dalla Pozza L, et al. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto region\u2019s rare diseases registry. Orphanet J Rare Dis. 2014;9:37.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"3704_CR10","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1111\/ene.14852","volume":"28","author":"ATG Chiu","year":"2021","unstructured":"Chiu ATG, Li J, Chang RSK, et al. Prevalence and healthcare utilization of rare neurological diseases in Hong Kong: 2014\u20132018. Eur J Neurol. 2021;28(7):2305\u201312.","journal-title":"Eur J Neurol"},{"key":"3704_CR11","doi-asserted-by":"publisher","first-page":"572006","DOI":"10.3389\/fneur.2020.572006","volume":"11","author":"YR Tong","year":"2020","unstructured":"Tong YR, Geng C, Guan YZ, et al. A comprehensive analysis of 2013 dystrophinopathies in China: A report from National rare disease center. Front Neurol. 2020;11:572006.","journal-title":"Front Neurol"},{"issue":"5","key":"3704_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/ijerph17051757","volume":"17","author":"X Yan","year":"2020","unstructured":"Yan X, He S, Dong D. Determining how Far an adult rare disease patient needs to travel for a definitive diagnosis: A Cross-Sectional examination of the 2018 National rare disease survey in China. Int J Environ Res Public Health. 2020;17(5):1757.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3704_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13023-019-1137-y","volume":"14","author":"X Shi","year":"2019","unstructured":"Shi X, Liu H, Zhan S, et al. Rare diseases in China: analysis of 2014\u20132015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals. Orphanet J Rare Dis. 2019;14(1):160.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3704_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13023-019-1168-4","volume":"14","author":"X Cai","year":"2019","unstructured":"Cai X, Yang H, Genchev GZ, et al. Analysis of economic burden and its associated factors of twenty-three rare diseases in Shanghai. Orphanet J Rare Dis. 2019;14(1):233.","journal-title":"Orphanet J Rare Dis"},{"key":"3704_CR15","doi-asserted-by":"crossref","unstructured":"Dong D, Wang Y. Challenges of rare diseases in China. Lancet. 2016;387(10031):1906.","DOI":"10.1016\/S0140-6736(16)30418-4"},{"key":"3704_CR16","unstructured":"Office of the leading group of the state council for the seventh national population census. China population census yearbook 2020. https:\/\/www.statsgovcn\/sj\/pcsj\/rkpc\/7rp\/zk\/indexchhtm"},{"issue":"40","key":"3704_CR17","first-page":"3274","volume":"98","author":"XM Shi","year":"2018","unstructured":"Shi XM, Liu H, Wang L, et al. Study on the current situation of China\u2019s first list of rare diseases based on 15 million hospitalizations. Zhonghua Yi Xue Za Zhi. 2018;98(40):3274\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"3704_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates [J]. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"12","key":"3704_CR19","doi-asserted-by":"publisher","first-page":"104062","DOI":"10.1016\/j.ejmg.2020.104062","volume":"63","author":"CC Chung","year":"2020","unstructured":"Chung CC, Wong WH, Fung JL, Hong Kong RD, Chung BH. Impact of COVID-19 pandemic on patients with rare disease in Hong Kong. Eur J Med Genet. 2020;63(12):104062.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"3704_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13023-023-02944-7","volume":"18","author":"M Mazzucato","year":"2023","unstructured":"Mazzucato M, Visona Dalla Pozza L, et al. Estimating mortality in rare diseases using a population-based registry, 2002 through 2019. Orphanet J Rare Dis. 2023;18(1):362.","journal-title":"Orphanet J Rare Dis"},{"key":"3704_CR21","unstructured":"X L. Descriptive epidemiology investigation and analysis of the rare disease in eight provinces, China. Master\u2019s Thesis, Pharmacy, Jinan University. 2020."},{"issue":"3","key":"3704_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5582\/irdr.2022.01093","volume":"11","author":"Y Lu","year":"2022","unstructured":"Lu Y, Gao Q, Ren X, et al. Incidence and prevalence of 121 rare diseases in China: current status and challenges: 2022 revision. Intractable Rare Dis Res. 2022;11(3):96\u2013104.","journal-title":"Intractable Rare Dis Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03704-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:37:14Z","timestamp":1744216634000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03704-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03704-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the first affiliated hospital of Sun Yat-sen University (No. [2024]035).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}